QuantumDx
The firm expects that next year it will launch the final version of a battery-powered instrument that can perform high-level multiplexing and provide test results in 30 minutes.
QuantumDx Gets CE Mark for Rapid Point-of-Care PCR System
The system will launch this week with a SARS-CoV-2 test, but the firm expects to expand its menu to include multiplex syndromic assays.
CARB-X Awards SpeeDx up to $3.7 Million for CT/NG Test on QuantumDx Q-POC
SpeeDx will develop a rapid, portable test for chlamydia and gonorrhea that can determine the latter's antimicrobial susceptibility, as well.
QuantuMDx Raises $15.1M to Support Scale Up of Point-of-Care Molecular Diagnostic System
The firm's CEO said that its MDx system is available for research use and going through CE-IVD marking ahead of its full commercial launch.
QuantuMDx Receives CE-IVD Marking for SARS-CoV-2 Test
The company said it has scaled up production capacity to two million reactions per week and has the potential to scale up to three million reactions per week.